Alterations In the Signaling Profile of Leukemic Progenitors Can Predict the Response of Myelodysplastic Syndrome (MDS) Patients to Azacytidine

被引：0
|
作者：
Miltiades, Paraskevi [1 ]
Bouchliou, Irene [1 ]
Nakou, Evangelia [1 ]
Spanoudakis, Emmanuil [1 ]
Papageorgiou, Sotirios [2 ]
Pappa, Vasiliki [2 ]
Papaioannou, Maria [3 ]
Moustakidis, Eleytherios [1 ]
Vakalopoulou, Sofia [4 ]
Garipidou, Vasilia [4 ]
Tsatalas, Konstantinos [1 ]
Kotsianidis, Ioannis [1 ]
机构：
[1] Democritus Univ Thrace, Alexandroupolis, Greece
[2] Univ Gen Hosp Atticon, Dept Internal Med 2, Hematol Unit, Athens, Greece
[3] Aristotle Univ Thessaloniki, AHEPA Hosp, GR-54006 Thessaloniki, Greece
[4] Aristotle Univ Thessaloniki, Propedeut Dept Internal Med 2, Hippokrat Hosp, GR-54006 Thessaloniki, Greece
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1204
页数：2
相关论文
共 50 条
  • [1] PLATELET RESPONSE AT SECOND CYCLE OF DECITABINE CAN PREDICT RESPONSE AND SURVIVAL FOR MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
    Jung, H. A.
    Jang, J.
    Kim, S.
    Maeng, C.
    Kim, K.
    Jung, C.
    HAEMATOLOGICA, 2012, 97 : 370 - 370
  • [2] The Levels of a G-CSF-Inducible pSTAT3+pSTAT5+Subpopulation of MDS Progenitors with Leukemic Stem Cell Phenotype Predict the Response to Azacytidine
    Miltiades, Paraskevi
    Labrianidou, Eleytheria
    Vassilakopoulos, Theodoros P.
    Papageorgiou, Sotirios G.
    Galanopoulos, Athanasios G.
    Vakalopoulou, Sofia
    Garypidou, Vassilia
    Nakou, Evangelia
    Spanoudakis, Emmanuil
    Papaioannou, Maria
    Papadaki, Helen A.
    Pappa, Vasiliki
    Tsatalas, Konstantinos
    Kotsianidis, Ioannis
    BLOOD, 2012, 120 (21)
  • [3] Effect of Romiplostim in Patients (pts) with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Azacytidine
    Kantarjian, Hagop
    Giles, Frank
    Greenberg, Peter
    Paquette, Ronald
    Wang, Eunice
    Gabrilove, Janice
    Garcia-Mancro, Guillermo
    Gray, Julie
    Hu, Kuolung
    Franklin, Janet
    BLOOD, 2008, 112 (11) : 89 - 90
  • [4] A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
    Wang, Yu-Hung
    Lin, Chien-Chin
    Yao, Chi-Yuan
    Hsu, Chia-Lang
    Hou, Hsin-An
    Tsai, Cheng-Hong
    Chou, Wen-Chien
    Tien, Hwei-Fang
    BLOOD ADVANCES, 2020, 4 (04) : 644 - 654
  • [5] CD34 positive progenitors can be cytogenetically normal in patients with myelodysplastic syndromes (MDS).
    Abruzzese, E
    Radford, JE
    Pettenati, MJ
    Rao, PN
    Hurd, DD
    Rainer, RO
    Powell, BL
    Torti, FM
    BLOOD, 1996, 88 (10) : 1906 - 1906
  • [6] Genetic instability in myelodysplastic syndrome (MDS): Microsatellite alterations occur in a substantial portion of patients with MDS.
    Maeck, L
    Hase, D
    Schoch, C
    Hiddemann, W
    Alves, F
    BLOOD, 1998, 92 (10) : 420A - 420A
  • [7] 5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients
    Costantini, Benedetta
    Kordasti, Shahram Y.
    Kulasekataraj, Austin G.
    Jiang, Jie
    Seidl, Thomas
    Abellan, Pilar Perez
    Hayden, Janet
    Farzaneh, Farzin
    Mufti, Ghulam J.
    BLOOD, 2011, 118 (21) : 358 - 358
  • [8] Genomic Biomarkers to Predict Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Sekeres, Mikkael A.
    Bejar, Rafael
    Komrokji, Rami S.
    Barnard, John
    Al-Issa, Karam
    Przychodzen, Bartlomiej P.
    Hirsch, Cassandra M.
    Steensma, David P.
    DeZern, Amy E.
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    Ebert, Benjamin L.
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130
  • [9] Do patients with low-grade myelodysplastic syndrome (MDS) mobilise normal hemopoietic progenitors?
    Mijovic, A
    Delforge, M
    Sekhavat, M
    Czepulkowski, B
    Ghulam, MJ
    BLOOD, 2000, 96 (11) : 149A - 149A
  • [10] AZACYTIDINE UPREGULATES PERFORIN EXPRESSION IN CYTOTOXIC T AND NATURAL KILLER CELLS OF RESPONDING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
    Miltiades, P.
    Lamprianidou, E.
    Vassilakopoulos, T. P.
    Papageorgiou, S. G.
    Galanopoulos, A. G.
    Vakalopoulou, S.
    Garypidou, V.
    Nakou, E.
    Papadaki, H. A.
    Spanoudakis, E.
    Tsatalas, C.
    Kotsianidis, I.
    LEUKEMIA RESEARCH, 2015, 39 : S141 - S141
12345